Yüklüyor......
Targeting PCSK9 for therapeutic gains
Even though it is only a little over a decade from the discovery of proprotein convertase subtilisin/kexin type 9 (PCSK9) as a plasma protein that associates with both hypercholesterolemia and low cholesterol syndromes, a rich literature has developed describing its unique physiology and the impact...
Kaydedildi:
| Yayımlandı: | Curr Atheroscler Rep |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5560054/ https://ncbi.nlm.nih.gov/pubmed/25712137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11883-015-0499-4 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|